Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

avVaa World Health Care Products Appoints Dr. Mario Zamora As Advisor to Its Board of Directors

Posted on: Thursday, 26 April 2007, 12:12 CDT

LUMBY, British Columbia, April 26 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (BULLETIN BOARD: AVVW) , a global biotechnology company offering therapeutic, natural skin and health care products, announced today that it has appointed a new advisor to its Board of Directors, Dr. Mario Zamora.

Dr. Zamora, a licensed Physician, received his PhD from University Autonomous of Nuevo Leon Medical School in Monterrey, Mexico. Dr. Zamora has a Master of Arts in Behavioral Sciences from University of Houston in Clear Lake, USA and is a Certified Christian Marriage and Family Therapist practicing in several parts of the southwestern United States and Mexico. He has been practicing in the medical psychotherapeutic field for over 20 years, has been a radio and TV talk show host on health issues for 15 years, and served as an advisor to several natural health companies for over a decade.

Dr. Mario Zamora said, "I am very excited to strengthen my existing relationship with avVaa. I've seen marked improvements in my patients' skin texture, overall appearance and comfort level, with the reduction of painful swelling and irritation, when using avVaa Care products. I look forward to working closely with the Board in helping the company increase product awareness to large populations suffering with Eczema, Psoriasis and Seborrheic Dermatitis."

Lorie Campbell-Farley, EVP of Sales and Marketing and Board Advisor for avVaa, stated, "Over the past year, it has been my pleasure to work with Dr. Zamora as he has taken on multiple studies of our products with extraordinary results. He has been instrumental in carving a market for us in the Texas region, and his expertise is a valuable addition to our board. Dr. Zamora reputation complements our outreach efforts in the national health care community."

Dr. Zamora studies with avVaa Care products reported the following: Rosacea - In damaged facial skin, avVaa Care products controlled this condition. With acne marks and damaged facial skin, including scars due to different factors, depending on the severity, avVaa Care products brought great results after 3 to 6 months of treatment. Hand and Foot Syndrome dermatitis caused by chemotherapy drugs, which affects the skin of hands and feet, including swollen, red, painful, cracking and peeling skin. With avVaa Care products, these effects are greatly alleviated after 3 to 6 months of treatment. avVaa Care products show promising results in aging skin where skin has lost its supple texture and appearance. With the use of avVaa Care products, a more natural and healthier appearance of the skin will be seen after a moderate length of time.

About avVaa World Health Care Products

avVaa World Health Care Products (AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

CONTACT:

At the Company: Jack Farley CEO / Chairman of avVaa at 1-866-772-8822 or visit: http://www.avvaa.com/ or http://www.otcfn.com/avvw.

Investor Relations: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781- 444-6100 ext. 625, rick@otcfn.com.

avVaa World Health Care Products Inc.

CONTACT: Jack Farley CEO-Chairman, +1-866-772-8822, or InvestorRelations, Merle Goertz (West Coast), +1-604-688-2349, both of avVaa WorldHealth Care Products, or Rick McCaffrey of OTC Financial Network,+1-781-444-6100, ext. 625, or rick@otcfn.com

Web site: http://www.avvaa.com/http://www.otcfn.com/avvw


Source: PRNewswire-FirstCall

More News in this Category


Related Articles



Rating: 3.5 / 5 (15 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required